“We’re thinking about a modular way of working, so if the technology develops very fast, we should be able to harness its potential quickly.”
- Thomas Dieffenbronn, Global Head of Strategy, Insights, and Technology, Global Clinical Operations, Novartis
What role can IT play in untangling increased trial complexity? Veeva’s Stephan Ohnmacht and Thomas Dieffenbronn (global head of strategy, insights, and technology for global clinical operations at Novartis) discuss how technology strategy in life sciences should strike a balance between quick fixes and innovation, and why simplicity holds the key to speeding up.
Contact the Veeva Business Consulting team to learn more about realizing the value of your technology investments.
More Customer Stories
HIPRA: Advancing Life Sciences Innovation
Watch the Interview
Watch the Interview
How Boehringer Ingelheim Deepened its Digital Transformation
See Why They Switched
See Why They Switched
Supporting Patient Choice with a Connected Platform
Discover the End-to-End Solution
Discover the End-to-End Solution